Unavailable
Unavailable
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/29/2024 | $5.00 | Outperform | Noble Capital Markets |
4/1/2022 | $4.00 | Neutral | Credit Suisse |
2/8/2022 | $9.00 → $5.00 | Equal Weight | Barclays |
2/8/2022 | $13.00 → $3.00 | Sector Perform | RBC Capital |
2/8/2022 | $20.00 → $4.00 | Overweight → Neutral | Piper Sandler |
2/8/2022 | $14.00 → $4.00 | Outperform → Neutral | Credit Suisse |
1/18/2022 | $21.00 → $9.00 | Overweight → Equal Weight | Barclays |
1/4/2022 | $11.00 | Outperform → In-Line | Evercore ISI Group |
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $307.2 million Net loss of $31.0 million Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.4 billion to $1.5 billion Net loss expected in a range of $42 million to $6 million Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment Highlights Senior Revenue of $114.1 million Adjusted EBITDA* of $27.9 million Approved Medicare Advantage policies of 107,272 Healthcare Services Revenue of $145.2 million Adjusted EBITDA* of $0.9 million Approximately 82,000 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (September 13, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=7297aa9f&confId=70516 After registering, a confirmation will be sent via email, including dial in details and unique conf
Third Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $376.4 million Net income of $8.6 million Adjusted EBITDA* of $46.6 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million Third Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $204.3 million Adjusted EBITDA* of $61.5 million Approved Medicar
10-K - SelectQuote, Inc. (0001794783) (Filer)
8-K - SelectQuote, Inc. (0001794783) (Filer)
10-Q - SelectQuote, Inc. (0001794783) (Filer)
Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $307.2 million Net loss of $31.0 million Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.4 billion to $1.5 billion Net loss expected in a range of $42 million to $6 million Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment Highlights Senior Revenue of $114.1 million Adjusted EBITDA* of $27.9 million Approved Medicare Advantage policies of 107,272 Healthcare Services Revenue of $145.2 million Adjusted EBITDA* of $0.9 million Approximately 82,000 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (September 13, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=7297aa9f&confId=70516 After registering, a confirmation will be sent via email, including dial in details and unique conf
SelectQuote, Inc. (NYSE:SLQT) today announced that SelectRx, the company's full-service medication management pharmacy that serves all 50 states, will open a third fulfillment facility in Olathe, Kansas, to serve its rapidly expanding customer base, alongside its existing facilities in Monaca, Pennsylvania, and Indianapolis, Indiana. SelectQuote launched the SelectRx business in 2021 as part of its Healthcare Services Division after acquiring two smaller pharmacy operations. In just over three years, SelectRx has grown its membership from under 5,000 to over 75,000 members who receive regular prescription shipments in adherence-friendly packaging. The new 54,000 square foot state-of-the-a
Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur
Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million
SelectQuote (NYSE:SLQT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $376.400 million which beat the analyst consensus estimate of $339.700 million by 10.80 percent. This is a 25.72 percent increase over sales of $299.398 million the same period last year.
Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00
Credit Suisse resumed coverage of SelectQuote with a rating of Neutral and set a new price target of $4.00
Barclays reiterated coverage of SelectQuote with a rating of Equal Weight and set a new price target of $5.00 from $9.00 previously
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)